AI & Emerging Technology

Winamp's Bridger platform is expanding globally to collect offline royalties, aiming to fix a broken system and pay artists what they are owed.

As anime fans demand immersive experiences over merchandise, one company is building a global network of permanent cultural arenas, transforming fandom into tourism.

InsurTech firm Pikl is redefining insurance, using it as a growth engine to solve the short-term rental market's biggest challenges and drive revenue.

Despite new regulations, LexinFintech's 2025 net profit surged 52.4%. See how risk management and a booming e-commerce arm fueled its resilience.

Graham Media Group appoints veteran digital strategist Stephanie Slagle as GM of WDIV, signaling a bold pivot to merge legacy journalism with digital growth.

Activist investor OneMove Capital accuses Sylogist's board of 'value destruction' and incompetence, setting the stage for a dramatic shareholder showdown.

A new partnership brings museum-quality contemporary art to a Santa Maria vineyard, offering a free cultural experience among the vines. But is it art or marketing?

Biotech firm ProMIS Neurosciences reveals novel vaccine data for ALS and Parkinson's, using a platform that selectively targets only toxic proteins.

With veteran leader Brian McKelligon at the helm, Infinity Bio aims to commercialize its powerful MIPSA platform and redefine precision medicine.

A new partnership integrates fifth wheel lock status with tire analytics, giving fleets a unified view to boost safety and prevent catastrophic failures.

Indian jeweler Aukera unveils its Extra Brilliant™ Solitaire, using light science and 2.5x more facets to challenge diamond industry traditions.

A new network for consumer ads is launching in 30,000 clinics, offering brands a trusted space but raising new questions about ethics and data privacy.

Activist investor Altai Capital launches a proxy fight at OraSure, alleging chronic underperformance and demanding board seats to force a strategic review.

Jaguar Uranium re-analyzes old drill cores in Colombia, hunting for rare earths in a bid to create a new, non-Chinese critical minerals hub for the West.

A new collaboration aims to predict immunotherapy success by mapping protein interactions, offering hope for personalized non-small cell lung cancer treatment.

After a year of major restructuring and a new CEO, Innovative Food Holdings' upcoming earnings call will reveal if its new strategy is paying off.

The abrdn Global Infrastructure Income Fund wants to remove its 2035 termination date, offering shareholders lower fees in exchange for a perpetual structure.

With a new CEO known for successful exits and a breakthrough PFA system for complex arrhythmias, Field Medical is poised to disrupt the cardiac ablation market.

The CRM provider launched a visual lead management tool to help agents organize prospects, automate follow-ups, and convert more deals.

The spinal device firm will meet investors at the key small-cap conference, balancing a story of innovation against mixed financial results.